Evidence map›Paper›PMID 36500224›Full record

ArticleMolecules (Basel, Switzerland)2022

Silver(I) Complexes Based on Oxadiazole-Functionalized

Shaima Hkiri, Kübra Açıkalın Coşkun, Elvan Üstün, Ali Samarat, Yusuf Tutar, Neslihan Şahin, David Sémeril

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Silver(I)-NHC Complexes as Dual-Action Agents Against PathogenicInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shaima HkiriSynthèse Organométallique et Catalyse, UMR-CNRS 7177, University of Strasbourg, 4 rue Blaise Pascal, 67008 Strasbourg, France.
Kübra Açıkalın CoşkunDepartment of Medical Biology and Genetics, Faculty of Medicine, University of İstanbul Aydın, Istanbul 34295, Turkey.ORCID 0000-0002-0047-8368
Elvan ÜstünDepartment of Chemistry, Faculty of Art and Science, University of Ordu, Ordu 52200, Turkey.
Ali SamaratLaboratory of Hetero-Organic Compounds and Nanostructured Materials (LR18ES11), Faculty of Sciences of Bizerte, University of Carthage, Bizerte 7021, Tunisia.ORCID 0000-0002-8334-7565
Yusuf TutarDepartment of Basic Pharmaceutical Sciences, Faculty of Pharmacy, University of Health Sciences-Turkey, Istanbul 34668, Turkey.
Neslihan ŞahinDepartment of Science Education, Faculty of Education, University of Cumhuriyet, Sivas 58140, Turkey.
David SémerilSynthèse Organométallique et Catalyse, UMR-CNRS 7177, University of Strasbourg, 4 rue Blaise Pascal, 67008 Strasbourg, France.ORCID 0000-0002-2582-4191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two silver(I) complexes, bis{diethyl[(5-phenyl-1,3,4-oxadiazol-2-yl-κ

Indexed as

OrganophosphonatesSilverLigandsMolecular Docking SimulationOxadiazolesVascular Endothelial Growth Factor ALigandsOrganophosphonatesOxadiazolesSilverVascular Endothelial Growth Factor A1,3,4-oxadiazolein vitro cytotoxicityMCF-7 cell linemolecular dockingPANC-1 cell linesilver(I) complexX-ray structure

Identifiers

PMID36500224
PMCPMC9738469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.